Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in CNTB — Connect Biopharma Holdings Ltd

CIK 1549230 NEW YORK, NY
Back to CNTB Full portfolio

Position in CNTB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,317,482
-$917,122 QoQ
Shares Held
973,732
-21.1% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3
of 55 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CNTB Over Time

Shares Held

Position Value (USD)

Derivatives in CNTB

reported options exposure · as of Mar 31, 2026
CallValue
$96,940
CallShares
37,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. CNTB ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in CNTB

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,317,482 973,732
2026-03-31 $96,940 37,000
2026-03-31 $3,234,604 1,234,582
2025-12-31 $104,340 37,000
2025-12-31 $3,481,521 1,234,582